Type 1 sodium-dependent phosphate transporter acts as a membrane potential-driven urate exporter

Takaaki Miyaji, Tatsuya Kawasaki, Natsuko Togawa, Hiroshi Omote, Yoshinori Moriyama

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

SLC17A1 protein (NPT1) was the first identified member of the SLC17 phosphate transporter family, and is known to mediate Na+/inorganic phosphate (Pi) co-transport when expressed in Xenopus oocytes. Although this protein was suggested to be a renal polyspecific anion exporter, its transport properties were not well characterized. The clean biochemical approach revealed that proteoliposomes comprising purified NPT1 as the only protein source transport various organic anions such as urate, p-aminohippuric acid (PAH), and acetylsalicylic acid (aspirin) in a membrane potential (δ̄)-driven and Cl- -dependent manner. Human NPT1 carrying an SNP mutation, Thr269Ile, known to increase the risk of gout, exhibited 32% lower urate transport activity compared to the wild type protein, leading to the conclusion that NPT1 is the long searched for transporter responsible for renal urate excretion. In the present article, we summarized the history of identification of the urate exporter and its possible involvement in the dynamism of urate under physiological and pathological conditions.

Original languageEnglish
Pages (from-to)88-94
Number of pages7
JournalCurrent Molecular Pharmacology
Volume6
Issue number2
DOIs
Publication statusPublished - 2013

Fingerprint

Sodium-Phosphate Cotransporter Proteins
Uric Acid
Membrane Potentials
Type III Sodium-Phosphate Cotransporter Proteins
Aspirin
Anions
Phosphate Transport Proteins
p-Aminohippuric Acid
Gout
Protein Transport
Xenopus
Oocytes
Single Nucleotide Polymorphism
Proteins
History
Phosphates
Kidney
Mutation

Keywords

  • Drug excretion
  • Gout
  • Membrane potential
  • Naspi_sup+spii_sup/inorganic phosphate transporter
  • Non-steroidal anti-inflammatory drug
  • Urate

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Molecular Medicine

Cite this

Type 1 sodium-dependent phosphate transporter acts as a membrane potential-driven urate exporter. / Miyaji, Takaaki; Kawasaki, Tatsuya; Togawa, Natsuko; Omote, Hiroshi; Moriyama, Yoshinori.

In: Current Molecular Pharmacology, Vol. 6, No. 2, 2013, p. 88-94.

Research output: Contribution to journalArticle

@article{c2c93ec909ab46969cd7433967adb006,
title = "Type 1 sodium-dependent phosphate transporter acts as a membrane potential-driven urate exporter",
abstract = "SLC17A1 protein (NPT1) was the first identified member of the SLC17 phosphate transporter family, and is known to mediate Na+/inorganic phosphate (Pi) co-transport when expressed in Xenopus oocytes. Although this protein was suggested to be a renal polyspecific anion exporter, its transport properties were not well characterized. The clean biochemical approach revealed that proteoliposomes comprising purified NPT1 as the only protein source transport various organic anions such as urate, p-aminohippuric acid (PAH), and acetylsalicylic acid (aspirin) in a membrane potential (δ̄)-driven and Cl- -dependent manner. Human NPT1 carrying an SNP mutation, Thr269Ile, known to increase the risk of gout, exhibited 32{\%} lower urate transport activity compared to the wild type protein, leading to the conclusion that NPT1 is the long searched for transporter responsible for renal urate excretion. In the present article, we summarized the history of identification of the urate exporter and its possible involvement in the dynamism of urate under physiological and pathological conditions.",
keywords = "Drug excretion, Gout, Membrane potential, Naspi_sup+spii_sup/inorganic phosphate transporter, Non-steroidal anti-inflammatory drug, Urate",
author = "Takaaki Miyaji and Tatsuya Kawasaki and Natsuko Togawa and Hiroshi Omote and Yoshinori Moriyama",
year = "2013",
doi = "10.2174/18744672113069990035",
language = "English",
volume = "6",
pages = "88--94",
journal = "Current Molecular Pharmacology",
issn = "1874-4702",
publisher = "Bentham Science Publishers",
number = "2",

}

TY - JOUR

T1 - Type 1 sodium-dependent phosphate transporter acts as a membrane potential-driven urate exporter

AU - Miyaji, Takaaki

AU - Kawasaki, Tatsuya

AU - Togawa, Natsuko

AU - Omote, Hiroshi

AU - Moriyama, Yoshinori

PY - 2013

Y1 - 2013

N2 - SLC17A1 protein (NPT1) was the first identified member of the SLC17 phosphate transporter family, and is known to mediate Na+/inorganic phosphate (Pi) co-transport when expressed in Xenopus oocytes. Although this protein was suggested to be a renal polyspecific anion exporter, its transport properties were not well characterized. The clean biochemical approach revealed that proteoliposomes comprising purified NPT1 as the only protein source transport various organic anions such as urate, p-aminohippuric acid (PAH), and acetylsalicylic acid (aspirin) in a membrane potential (δ̄)-driven and Cl- -dependent manner. Human NPT1 carrying an SNP mutation, Thr269Ile, known to increase the risk of gout, exhibited 32% lower urate transport activity compared to the wild type protein, leading to the conclusion that NPT1 is the long searched for transporter responsible for renal urate excretion. In the present article, we summarized the history of identification of the urate exporter and its possible involvement in the dynamism of urate under physiological and pathological conditions.

AB - SLC17A1 protein (NPT1) was the first identified member of the SLC17 phosphate transporter family, and is known to mediate Na+/inorganic phosphate (Pi) co-transport when expressed in Xenopus oocytes. Although this protein was suggested to be a renal polyspecific anion exporter, its transport properties were not well characterized. The clean biochemical approach revealed that proteoliposomes comprising purified NPT1 as the only protein source transport various organic anions such as urate, p-aminohippuric acid (PAH), and acetylsalicylic acid (aspirin) in a membrane potential (δ̄)-driven and Cl- -dependent manner. Human NPT1 carrying an SNP mutation, Thr269Ile, known to increase the risk of gout, exhibited 32% lower urate transport activity compared to the wild type protein, leading to the conclusion that NPT1 is the long searched for transporter responsible for renal urate excretion. In the present article, we summarized the history of identification of the urate exporter and its possible involvement in the dynamism of urate under physiological and pathological conditions.

KW - Drug excretion

KW - Gout

KW - Membrane potential

KW - Naspi_sup+spii_sup/inorganic phosphate transporter

KW - Non-steroidal anti-inflammatory drug

KW - Urate

UR - http://www.scopus.com/inward/record.url?scp=84882775616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882775616&partnerID=8YFLogxK

U2 - 10.2174/18744672113069990035

DO - 10.2174/18744672113069990035

M3 - Article

AN - SCOPUS:84882775616

VL - 6

SP - 88

EP - 94

JO - Current Molecular Pharmacology

JF - Current Molecular Pharmacology

SN - 1874-4702

IS - 2

ER -